Practical scenarios and day-to-day challenges in the management of diabetes in COVID-19 — Dealing with the ‘double trouble’

COVID-19 and diabetes: Knowledge in progress

(2020) Akhtar Hussain et al.   DIABETES RESEARCH AND CLINICAL PRACTICE

Kidney disease is associated with in-hospital death of patients with COVID-19

(2020) Yichun Cheng et al.   KIDNEY INTERNATIONAL

Diabetic Ketoacidosis in COVID-19: Unique Concerns and Considerations

(2020) Nadine E Palermo et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

New-Onset Diabetes in Covid-19

(2020) Francesco Rubino et al.   NEW ENGLAND JOURNAL OF MEDICINE

Dexamethasone in Hospitalized Patients with Covid-19 — Preliminary Report

(2020)   NEW ENGLAND JOURNAL OF MEDICINE

Compassionate remdesivir treatment of severe Covid-19 pneumonia in intensive care unit (ICU) and Non-ICU patients: Clinical outcome and differences in post-treatment hospitalisation status

(2020) Spinello Antinori et al.   PHARMACOLOGICAL RESEARCH

COVID-19 in people with diabetes: understanding the reasons for worse outcomes

(2020) Matteo Apicella et al.   Lancet Diabetes & Endocrinology

Associations of type 1 and type 2 diabetes with COVID-19-related mortality in England: a whole-population study

(2020) Emma Barron et al.   Lancet Diabetes & Endocrinology

Inpatient use of glucocorticoids may mediate the detrimental effect of new-onset hyperglycemia on COVID-19 severity

(2020) Gerui Li   DIABETES RESEARCH AND CLINICAL PRACTICE